Table 3.
Psychiatric symptoms and cognitive evaluation score, depending on the presence of NBD.
| All Patients | Neuro-Behçet’s | Non-Neuro-Behçet’s | p | |
|---|---|---|---|---|
| MINI | n = 20 | n = 5 | n = 15 | |
| Present depression | 1 | 0 | 1 | 1 |
| Past depression | 1 | 0 | 1 | 1 |
| SCL-90 n, % | n = 18 | n = 4 | n = 14 | |
| Somatization | 8, 44.4% | 2 (50) | 6 (43) | 1 |
| Compulsiveness | 4, 22.2% | 1 (25) | 3 (21) | 1 |
| Social inhibition | 5, 27.8% | 2 (50) | 3 (21) | 0.53 |
| Depression | 4, 22.2% | 1 (25) | 3 (21) | 1 |
| Anxiety | 9, 50.0% | 4 (100) | 5 (36) | 0.08 |
| Hostility | 3, 16.7% | 1 (25) | 2 (14) | 1 |
| Phobia | 5, 27.8% | 2 (50) | 3 (21) | 0.53 |
| Paranoia | 4, 22.2% | 1 | 3 | |
| Psychotism | 4, 22.2% | 0 (0) | 4 (29) | 0.52 |
| Sleep disorder | 8, 44.4% | 3 (75) | 5 (36) | 0.27 |
| Psychopathology | 8, 44.4% | 3 (75) | 5 (36) | 0.27 |
| Global severity Index, median [IQR] Severity |
0.405 [0.2–0.7] | 0.67 [0.63–0.70] | 0.26 [0.16–0.60] | 0.03 |
| Pathological | 2, 11.1% | 0 (0) | 2 (14) | |
| Moderate | 7, 38.9% | 4 (100) | 3 (21) | 0.02 |
| Absent | 9, 50.0% | 0 (0) | 9 (64) | |
| Positive Symptom Distress Index [IQR] | ||||
| Pathological | 4, 22.2% | 2 (50) | 2 (14) | |
| Moderate | 8, 44.4% | 2 (50) | 6 (43) | 0.17 |
| Absent | 6, 33.3% | 0 (0) | 6 (43) | |
| Mac Nair significant complaint (>54) n (%) | 4 (21.1%) | 0 (0) | 4 (27) | 0.53 |
| Memory Span n (%) | ||||
| Satisfying | 2 (10.5%) | 1 | 1 | 0.55 |
| Intermediate | 9 (47.4%) | 2 | 7 | |
| Below average | 4 (21.1%) | 0 | 4 | |
| Insufficient | 4 (21.1%) | 1 | 3 | |
| Weschler Adult Intelligence Scale subtest (Code test) n (%) | n = 3 | |||
| Satisfying | 1/18 (5.6%) | 0 | 1 | 0.86 |
| Intermediate | 10/18 (55.6%) | 2 | 8 | |
| Insufficient | 7/18 (38.9%) | 1 | 6 | |
| Phonemic fluency insufficiency, n (%) | 3 (15.8%) | 0 (0) | 3 (20) | 1 |
| Semantic fluency insufficiency, n (%) | 8 (42.1%) | 1 (25) | 7 (47) | 0.60 |
| Hopkins Verbal Learning Test, insufficiency, n (%) | 12 (63.2%) | 2 (50) | 10 (67) | 0.60 |
| Trail Making Test insufficiency, n (%) | 7/17 (41,2%) | 0/3 (0) | 7/14 (50) | 0.23 |
| Insufficiency ≥ 3 tests | 9/19 (47.3%) | 1 (25) | 8 (57) | 0.58 |
The between-groups comparisons were performed using the Mann–Whitney U, the χ² or exact Fisher test when appropriate. Statistical significance was p < 0.05. Significant comparisons are in bold. There was no difference in frequency of psychological symptoms between BD patients and NBD patients except for a trend in anxiety (p = 0.08). GSI was higher in NBD patients than in BD patients (p = 0.03). Cognitive impairment was frequent regardless of specific cerebral involvement.